FalconX group discloses 16.5% stake in Sharps
Sharps Technology, Inc. now has a significant new shareholder group led by FalconX affiliates.
Rhea-AI Filing Summary
Sharps Technology, Inc. now has a significant new shareholder group led by FalconX affiliates. FalconX Holdings Limited may be deemed to beneficially own 6,563,498 shares of common stock, or about 16.5% of the company, including shares issuable from stapled warrants that are exercisable within 60 days based on 33,363,003 shares outstanding as of January 20, 2026.
Subsidiaries Solios, Inc. and FalconX Alpha, Inc. each may be deemed to beneficially own 5,794,268 shares, or roughly 14.9%. MNNC-related funds and entities together hold smaller positions primarily through cash stapled warrants. On January 9, 2026, Solios acquired 461,538 shares through a cashless exercise of cash pre-funded warrants, while MNNC Master Fund and MNNC BTC Master Fund sold shares in open-market trades at prices around $1.93 to $1.97 per share.
The investor group states the securities were acquired for investment and to gain exposure to Sharps Technology’s business and growth prospects. They are already in discussions with management and the board regarding strategy, governance, and potential changes to the board and business approach, though they do not currently commit to specific transactional plans.
Positive
- None.
Negative
- None.
Insights
FalconX-led group reports a concentrated 16.5% stake and begins strategic talks with Sharps Technology.
The disclosure shows a FalconX-controlled structure holding a sizeable position in Sharps Technology, mainly via warrants. FalconX Holdings may be deemed to own 6,563,498 shares, or about 16.5%, while Solios and FalconX Alpha each sit around 14.9% beneficial ownership on a 33,363,003-share base as of January 20, 2026.
The position is complex, combining common stock with cash and cryptocurrency stapled warrants. A 9.99% beneficial ownership limitation on cryptocurrency pre-funded warrants caps how much can be exercised at once, while stapled warrants are exercisable within 60 days. This structure shapes how quickly economic exposure can translate into voting power.
The group describes its stake as an investment but is already discussing business strategy, financial condition, governance, and possible board and management changes with the company. Future actions, such as additional purchases, warrant exercises, or sales, are left open, suggesting that later disclosures in company and shareholder reports will clarify how actively this investor group influences Sharps Technology’s direction.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Sharps Technology (STSS) does FalconX Holdings report?
How much of Sharps Technology (STSS) do Solios, Inc. and FalconX Alpha, Inc. own?
What recent transactions involving Sharps Technology (STSS) did Solios, Inc. complete?
How did the MNNC funds adjust their Sharps Technology (STSS) holdings?
What are the key warrant terms affecting Sharps Technology (STSS) ownership?
How does the FalconX group plan to engage with Sharps Technology (STSS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.